
Oncology
Tecentriq & Avastin for Hepatocellular Carcinoma
A look at the combination immunotherapy approach reshaping first-line HCC treatment.
Download PDFIn-depth articles on the market shifts, science, and strategy shaping life-sciences and adjacent industries — free to read, free to share.

A look at the combination immunotherapy approach reshaping first-line HCC treatment.
Download PDF
How the pandemic reset R&D timelines, supply chains, and global drug demand patterns.
Download PDF
Pricing, manufacturing complexity, and payer pushback for one-time curative treatments.
Download PDF
Decades of failed clinical trials and what the next wave of disease-modifying drugs faces.
Download PDF
A plain-English walkthrough of payers, formularies, and patient access pathways.
Download PDF
Epidemiology, transmission, and the state of vaccine development for an emerging zoonotic threat.
Download PDF
Analysing the $62 B Shire acquisition — strategic rationale vs financial reality.
Download PDF